IMPACT OF PEGYLATED INTERFERON α2B PLUS RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Ogawa, E. [1 ]
Furusyo, N. [1 ]
Kajiwara, E. [1 ]
Takahashi, K. [1 ]
Nomura, H. [1 ]
Tanabe, Y. [1 ]
Satoh, T. [1 ]
Maruyama, T. [1 ]
Nakamuta, M. [1 ]
Kotoh, K. [1 ]
Azuma, K. [1 ]
Dohmen, K. [1 ]
Shimoda, S. [1 ]
Hayashi, J. [1 ]
机构：
[1] Kyushu Univ, Liver Dis Study KULDS Grp, Fukuoka 812, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1145
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [21] Treatment of chronic hepatitis C in HIV-infected patients with interferon α-2b plus ribavirin
    Pérez-Olmeda, M
    Soriano, V
    Asensi, V
    Morales, D
    Romero, M
    Ochoa, A
    Sánchez-Montero, F
    Santin, M
    Guardiola, J
    Blanch, J
    Núñez, M
    Jiménez-Nácher, I
    García-Samaniego, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (12) : 1083 - 1089
  • [22] Treatment of chronic hepatitis C in HIV infected patients (pts) with pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b
    Cargnel, A
    Angeli, E
    Mainini, A
    Casella, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, PG
    JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
  • [23] Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
    Siebert, U
    Sroczynski, G
    Rossol, S
    Wasem, J
    Ravens-Sieberer, U
    Kurth, BM
    Manns, MP
    McHutchison, JG
    Wong, JB
    GUT, 2003, 52 (03) : 425 - 432
  • [24] Late onset autoimmune thrombocytopenia associated with pegylated interferon-α-2b plus ribavirin treatment for chronic hepatitis C
    Elefsiniotis, IS
    Pantazis, KD
    Fotos, NV
    Moulakakis, A
    Mavrogiannis, C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 622 - 623
  • [25] IMPACT OF THE VIRAL KINETICS OF CHRONIC HEPATITIS C PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGYLATED INTERFERON α2b AND RIBAVIRIN
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S365 - S365
  • [26] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [27] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [28] Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C
    Yamashita, Naoki
    Enjoji, Munechika
    Kotoh, Kazuhiro
    Kato, Masaki
    Ueda, Akihiro
    Horikawa, Yuki
    Tajiri, Hirotaka
    Higuchi, Nobito
    Kinukawa, Naoko
    Nakamuta, Makoto
    Takayanagi, Ryoichi
    JOURNAL OF DIGESTIVE DISEASES, 2008, 9 (01) : 27 - 31
  • [29] PEGYLATED INTERFERON ALPHA PLUS RIBAVIRIN TREATMENT OF CHRONIC HEPATITIS C IN PSORIATIC PATIENTS
    Tomasiewicz, Krzysztof
    Modrzewska, Romana
    HEPATOLOGY, 2008, 48 (04) : 907A - 907A
  • [30] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
12345